Found: 45
Select item for more details and to access through your institution.
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. C1, doi. 10.1111/dom.15460
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 405, doi. 10.1111/dom.15127
- Publication type:
- Article
Pathophysiological interactions between sarcopenia and type 2 diabetes: A two‐way street influencing diagnosis and therapeutic options.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 407, doi. 10.1111/dom.15321
- By:
- Publication type:
- Article
Non‐steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 417, doi. 10.1111/dom.15327
- By:
- Publication type:
- Article
Metabolically healthy obese individuals are still at high risk for diabetes: Application of the marginal structural model.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 431, doi. 10.1111/dom.15329
- By:
- Publication type:
- Article
Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 441, doi. 10.1111/dom.15331
- By:
- Publication type:
- Article
5‐Year simulation of diabetes‐related complications in people treated with tirzepatide or semaglutide versus insulin glargine.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 463, doi. 10.1111/dom.15332
- By:
- Publication type:
- Article
Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 473, doi. 10.1111/dom.15333
- By:
- Publication type:
- Article
Metabolic syndrome, genetic susceptibility, and risk of chronic obstructive pulmonary disease: The UK Biobank Study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 482, doi. 10.1111/dom.15334
- By:
- Publication type:
- Article
Effects of hypoglycaemic agents on reducing surrogate metabolic parameters for the prevention of cardiovascular events and death in patients with type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 495, doi. 10.1111/dom.15335
- By:
- Publication type:
- Article
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 503, doi. 10.1111/dom.15336
- By:
- Publication type:
- Article
Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real‐world observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 512, doi. 10.1111/dom.15337
- By:
- Publication type:
- Article
In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: A prospective cohort study from the UK Biobank.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 524, doi. 10.1111/dom.15338
- By:
- Publication type:
- Article
Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 532, doi. 10.1111/dom.15339
- By:
- Publication type:
- Article
Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 540, doi. 10.1111/dom.15341
- By:
- Publication type:
- Article
Impact of a dual glucose‐dependent insulinotropic peptide/glucagon‐like peptide‐1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 548, doi. 10.1111/dom.15342
- By:
- Publication type:
- Article
Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 557, doi. 10.1111/dom.15344
- By:
- Publication type:
- Article
Weight change in patients with new‐onset type 2 diabetes mellitus and its association with remission: Comprehensive real‐world data.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 567, doi. 10.1111/dom.15345
- By:
- Publication type:
- Article
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post‐hoc analysis of the ROTATE‐3 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 576, doi. 10.1111/dom.15346
- By:
- Publication type:
- Article
Utility of serum β2‐microglobulin for prediction of kidney outcome among patients with biopsy‐proven diabetic nephropathy.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 583, doi. 10.1111/dom.15347
- By:
- Publication type:
- Article
A model‐informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong‐acting dipeptidyl peptidase‐4 inhibitor.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 592, doi. 10.1111/dom.15348
- By:
- Publication type:
- Article
Global trends in the burden of chronic kidney disease attributable to type 2 diabetes: An age‐period‐cohort analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 602, doi. 10.1111/dom.15349
- By:
- Publication type:
- Article
Factors that determine glucose variability, defined by the coefficient of variation in continuous glucose monitoring values, in a Chinese population with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 611, doi. 10.1111/dom.15350
- By:
- Publication type:
- Article
Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP+ randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 622, doi. 10.1111/dom.15351
- By:
- Publication type:
- Article
Impact of a 4‐week intensive track and field training intervention on glycaemia in adolescents with type 1 diabetes: The ChilDFiT1 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 631, doi. 10.1111/dom.15352
- By:
- Publication type:
- Article
Effects of CB1R inverse agonist, INV‐202, in patients with features of metabolic syndrome. A randomized, placebo‐controlled, double‐blind phase 1b study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 642, doi. 10.1111/dom.15353
- By:
- Publication type:
- Article
Non‐alcoholic fatty liver disease is associated with brain function disruption in type 2 diabetes patients without cognitive impairment.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 650, doi. 10.1111/dom.15354
- By:
- Publication type:
- Article
Establishment and validation of a prediction model for gestational diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 663, doi. 10.1111/dom.15356
- By:
- Publication type:
- Article
Effect of artificial pancreas system use on glycaemic control among pregnant women with type 1 diabetes mellitus: A meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 673, doi. 10.1111/dom.15357
- By:
- Publication type:
- Article
One‐hour post‐load glucose levels are associated with hepatic steatosis assessed by transient elastography.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 682, doi. 10.1111/dom.15358
- By:
- Publication type:
- Article
Beinaglutide for weight management in Chinese individuals with overweight or obesity: A phase 3 randomized controlled clinical study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 690, doi. 10.1111/dom.15360
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors are associated with kidney benefits at all degrees of albuminuria: A retrospective cohort study of adults with diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 699, doi. 10.1111/dom.15361
- By:
- Publication type:
- Article
Effect of the dual sodium‐glucose co‐transporter‐1 and ‐2 inhibitor sotagliflozin on renal outcomes in type 1 diabetes and type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 710, doi. 10.1111/dom.15364
- By:
- Publication type:
- Article
Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 721, doi. 10.1111/dom.15367
- By:
- Publication type:
- Article
FOXO1 reduces STAT3 activation and causes impaired mitochondrial quality control in diabetic cardiomyopathy.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 732, doi. 10.1111/dom.15369
- By:
- Publication type:
- Article
Improvement of early‐phase insulin secretion is an independent factor for achieving glycaemic control: A pooled analysis of SEED and DAWN study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 745, doi. 10.1111/dom.15370
- By:
- Publication type:
- Article
Nasal glucagon is safe and effective in children and adolescents with type 1 diabetes: A real‐world prospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 754, doi. 10.1111/dom.15330
- By:
- Publication type:
- Article
Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 758, doi. 10.1111/dom.15340
- By:
- Publication type:
- Article
Implementing Control‐IQ technology after a virtual educational camp in children and adolescents with type 1 diabetes: Does time in range plateau over 1 year?
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 763, doi. 10.1111/dom.15343
- By:
- Publication type:
- Article
Artemisinin alleviates obesity‐related glomerulopathy by downregulating CYP24A1 expression.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 767, doi. 10.1111/dom.15355
- By:
- Publication type:
- Article
Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open‐label, controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 772, doi. 10.1111/dom.15359
- By:
- Publication type:
- Article
Obesity attenuates acute phosphate excretion after an oral challenge in females: A sex‐specific effect of obesity on phosphate handling.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 777, doi. 10.1111/dom.15362
- By:
- Publication type:
- Article
Semaglutide, suicidal ideation and behaviour: A resting state functional magnetic resonance imaging perspective.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 782, doi. 10.1111/dom.15363
- By:
- Publication type:
- Article
Improvements in post‐challenge lipid response following tirzepatide treatment in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 785, doi. 10.1111/dom.15365
- By:
- Publication type:
- Article
Correction to Clinical features of generalized lipodystrophy in Turkey: A cohort analysis.
- Published in:
- 2024
- Publication type:
- Correction Notice